Live Quote · NASDAQERASHealthcare· Biotechnology

Erasca, Inc.

$13.61▼ 4.29%($-0.61)
MKT CAP $4.78BNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
67
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ERAS research report →

Analyst Price Target
$20.67+51.9% vs. today

Range $16 – $24

Analyst RatingBuy
9 Buy2 Hold0 Sell

Price Chart

+389.57% · this period
$22.47$12.63$2.78Nov 20May 26Nov 20
52-Week Range50% of range
Low
$2.75
Current
$13.61
High
$24.28